Global Psoriasis Drugs Market Will Continue to Grow at 7.30% CAGR by 2021
Psoriasis Drugs Market by Drug Type, by Route of Administration, by Target, and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (20162021)
(EMAILWIRE.COM, April 11, 2017 ) According to the report Global Psoriasis Drugs , published by Market Data Forecast, the global market projected to reach USD 10.8 billion by 2021, at a CAGR of 7.30% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/global-psoriasis-drugs-market-1718/
Psoriasis is inflammatory, non-communicable skin condition that alters the life cycle of skin cells by speeding up the cell building process on the surface of the skin. Rapid development of cells produces thick, silver scales, and makes the skin red, itchy, dry, and flaky. The various types of psoriasis are guttate, erythrodermic, inverse, vulgaris, pustular, palmoplantar, nail, and scalp psoriasis. According to International Federation of Psoriasis Drugs market Association, approximately 3% or more than 125 million of the worlds population are living with psoriasis. Additionally, approximately 10% of the population has severe form of psoriasis, among diagnosed population, and 90% of the people fall under moderate to mild category of psoriasis.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-psoriasis-drugs-market-1718/request-sample
Currently, no permanent cure is available for the disease; however preventative measures can be adopted to slow down the growth of cells on the surface of the skin. Psoriasis can be treated either with pharmaceuticals or biopharmaceuticals therapies through systemic and topical process. These medications when administered, either by consumed orally, or applying on the skin, or through injections, specifically block parts of immune system process by targeting Tumour Necrosis Factor, Interleukin, Phosphodiesterase Type 4, among others.
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-psoriasis-drugs-market-1718/inquire
The growth of Psoriasis Drugs is majorly driven by factors such as rising healthcare expenditure, boost in psoriasis Research and Development investment, introduction of novel and more efficient drug, and increasing demand of psoriasis medicines in emerging economies. Additionally, psoriasis requires long term treatment as it may again reoccur after the first line treatment, thereby increasing sales revenue. Also, with the availability of better diagnostic devices will result in building confidence in people, thereby resulting in growing treatment-seeking population. People seeking treatment for Psoriasis are started showing interest in combination therapies. A combination therapy of Topical and Systemic (Etanercept, Alefacept, and others taken with methotrexate) has shown better results in patient. Expected entry of late-stage pipeline products (Xeljanz and the biosimilar adalimumab by Pfizer) is anticipated to accelerate the growth of the product.
Buy now http://www.marketdataforecast.com/cart/buy-now/global-psoriasis-drugs-market-1718
The key constraints of the market are high cost involved in drug development, increasing availability of generic products, patent expiry of brand name drugs, side effects from the systemic and biologics medication (liver and kidney damage, infection, high blood pressure, and cancer of the lymph nodes), health insurance issues, lack of access to healthcare, and low efficacy of the product.
The products are segmented based on Drug Type, Route of Administration, and Target and studied for a deep-level understanding of the Psoriasis Drugs Market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Based on Drug Type:
Introduction
Pharmaceuticals
Biopharmaceuticals
Y-o-Y Growth Analysis, By Drug Type
Market Attractiveness Analysis, By Drug Type
Market Share Analysis, By Drug Type
Based on Route of Administration:
Introduction
Topical
Systemic
Oral
Intravenous
Other
Y-o-Y Growth Analysis, By Route of Administration
Market Attractiveness Analysis, By Route of Administration
Market Share Analysis, By Route of Administration
Based on Target:
Introduction
Tumour Necrosis Factor (TNF)
Phosphodiesterase Type 4 (PDE4)
Interleukin
Others
Y-o-Y Growth Analysis, By Target
Market Attractiveness Analysis, By Target
Market Share Analysis, By Target
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 41% in 2016 followed by Europe. Asia Pacific is witnessing the fastest growing region for the product with a CAGR of 8.24% during the forecast period 2016-2021.
Geographical Segmentation:
North America Psoriasis Drugs Market
Europe Psoriasis Drugs Market
Asia-pacific Psoriasis Drugs Market
Latin America Psoriasis Drugs Market
Middle East and Africa Psoriasis Drugs Market
The key players in Global Psoriasis Drugs Market are Johnson & Johnson (USA), Janssen Biotech Inc (USA), Stiefel Laboratories Inc (USA), Pfizer Inc (USA), Merck and Co. Inc (USA), Celgene Corporation (USA), Takeda Pharmaceutical Company Limited (Japan), Novartis International AG (Switzerland), Amgen (USA), and AbbVie (USA).
The Psoriasis Drugs Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of Drug Type, Route of Administration, and Target along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Immunotherapy Drugs market: http://www.marketdataforecast.com/market-reports/global-immunotherapy-drugs-market-1156/
Orphan Drugs Market: http://www.marketdataforecast.com/market-reports/global-orphan-drugs-market-1676/
Antiviral Drugs Market: http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/
Influenza Market: http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
Anticoccidial Drugs Market: http://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market-13/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more info kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
For full report refer to http://www.marketdataforecast.com/market-reports/global-psoriasis-drugs-market-1718/
Psoriasis is inflammatory, non-communicable skin condition that alters the life cycle of skin cells by speeding up the cell building process on the surface of the skin. Rapid development of cells produces thick, silver scales, and makes the skin red, itchy, dry, and flaky. The various types of psoriasis are guttate, erythrodermic, inverse, vulgaris, pustular, palmoplantar, nail, and scalp psoriasis. According to International Federation of Psoriasis Drugs market Association, approximately 3% or more than 125 million of the worlds population are living with psoriasis. Additionally, approximately 10% of the population has severe form of psoriasis, among diagnosed population, and 90% of the people fall under moderate to mild category of psoriasis.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-psoriasis-drugs-market-1718/request-sample
Currently, no permanent cure is available for the disease; however preventative measures can be adopted to slow down the growth of cells on the surface of the skin. Psoriasis can be treated either with pharmaceuticals or biopharmaceuticals therapies through systemic and topical process. These medications when administered, either by consumed orally, or applying on the skin, or through injections, specifically block parts of immune system process by targeting Tumour Necrosis Factor, Interleukin, Phosphodiesterase Type 4, among others.
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-psoriasis-drugs-market-1718/inquire
The growth of Psoriasis Drugs is majorly driven by factors such as rising healthcare expenditure, boost in psoriasis Research and Development investment, introduction of novel and more efficient drug, and increasing demand of psoriasis medicines in emerging economies. Additionally, psoriasis requires long term treatment as it may again reoccur after the first line treatment, thereby increasing sales revenue. Also, with the availability of better diagnostic devices will result in building confidence in people, thereby resulting in growing treatment-seeking population. People seeking treatment for Psoriasis are started showing interest in combination therapies. A combination therapy of Topical and Systemic (Etanercept, Alefacept, and others taken with methotrexate) has shown better results in patient. Expected entry of late-stage pipeline products (Xeljanz and the biosimilar adalimumab by Pfizer) is anticipated to accelerate the growth of the product.
Buy now http://www.marketdataforecast.com/cart/buy-now/global-psoriasis-drugs-market-1718
The key constraints of the market are high cost involved in drug development, increasing availability of generic products, patent expiry of brand name drugs, side effects from the systemic and biologics medication (liver and kidney damage, infection, high blood pressure, and cancer of the lymph nodes), health insurance issues, lack of access to healthcare, and low efficacy of the product.
The products are segmented based on Drug Type, Route of Administration, and Target and studied for a deep-level understanding of the Psoriasis Drugs Market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Based on Drug Type:
Introduction
Pharmaceuticals
Biopharmaceuticals
Y-o-Y Growth Analysis, By Drug Type
Market Attractiveness Analysis, By Drug Type
Market Share Analysis, By Drug Type
Based on Route of Administration:
Introduction
Topical
Systemic
Oral
Intravenous
Other
Y-o-Y Growth Analysis, By Route of Administration
Market Attractiveness Analysis, By Route of Administration
Market Share Analysis, By Route of Administration
Based on Target:
Introduction
Tumour Necrosis Factor (TNF)
Phosphodiesterase Type 4 (PDE4)
Interleukin
Others
Y-o-Y Growth Analysis, By Target
Market Attractiveness Analysis, By Target
Market Share Analysis, By Target
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 41% in 2016 followed by Europe. Asia Pacific is witnessing the fastest growing region for the product with a CAGR of 8.24% during the forecast period 2016-2021.
Geographical Segmentation:
North America Psoriasis Drugs Market
Europe Psoriasis Drugs Market
Asia-pacific Psoriasis Drugs Market
Latin America Psoriasis Drugs Market
Middle East and Africa Psoriasis Drugs Market
The key players in Global Psoriasis Drugs Market are Johnson & Johnson (USA), Janssen Biotech Inc (USA), Stiefel Laboratories Inc (USA), Pfizer Inc (USA), Merck and Co. Inc (USA), Celgene Corporation (USA), Takeda Pharmaceutical Company Limited (Japan), Novartis International AG (Switzerland), Amgen (USA), and AbbVie (USA).
The Psoriasis Drugs Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of Drug Type, Route of Administration, and Target along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Immunotherapy Drugs market: http://www.marketdataforecast.com/market-reports/global-immunotherapy-drugs-market-1156/
Orphan Drugs Market: http://www.marketdataforecast.com/market-reports/global-orphan-drugs-market-1676/
Antiviral Drugs Market: http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/
Influenza Market: http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
Anticoccidial Drugs Market: http://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market-13/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more info kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results